4.4 Review

Pharmaceutical applications of hot-melt extrusion: Part II

期刊

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
卷 33, 期 10, 页码 1043-1057

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/03639040701525627

关键词

hot-melt extrusion; solid dispersion; bioavailability; melt-extruded tablets; drug delivery systems; melt extruded films

资金

  1. NCRR NIH HHS [P20RR021929] Funding Source: Medline
  2. NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021929] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The advent of high through-put screening in the drug discovery process has resulted in compounds with high lipophilicity and poor solubility. Increasing the solubility of such compounds poses a major challenge to formulation scientists. Various approaches have been adopted to address this including preparation of solid dispersions and solid solutions. Hot-melt extrusion is an efficient technology for producing solid molecular dispersions with considerable advantages over solvent-based processes such as spray drying and co-precipitation. Hot-melt extrusion has been demonstrated to provide sustained, modified, and targeted drug delivery. Improvements in bioavailability utilizing the hot-melt extrusion technique demonstrate the value of the technology as a potential drug delivery processing tool. The interest in hot-melt extrusion technology for pharmaceutical applications is evident from the increasing number of patents and publications in the scientific literature. Part II of this article reviews the myriad of hot-melt extrusion applications for pharmaceutical dosage forms including granules, pellets, tablets, implants, transmucosal, and transdermal systems.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据